secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0000950170-25-072700
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics prices $5.0M follow-on offering at $7.45/unit, amends existing warrants
--------------------------------------------------------------------------------

- 671,140 units priced at $7.45/unit, each consisting of one share (or pre-funded warrant) and two warrants.
- Gross proceeds of $5.0M; closed May 15, 2025; Maxim Group as sole placement agent.
- Amended existing warrants for 167,925 shares, reducing exercise price from $41.20 to $7.45 per share.
- Warrants exercisable immediately at $7.45, expire in five years; pre-funded warrants at $0.0001, no expiration.
- Proceeds to fund clinical trials for HCW9302, business development, R&D, and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025072700/0000950170-25-072700-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025072700/hcwb-20250513.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-072700

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer